The U.S. NIH’s COVID-19 Treatment Guidelines Panel today announced a change to its previous recommendations for COVID-19 treatments.
The purpose of this new NIH statement is to provide clinicians with guidance on the role of bebtelovimab a U.S. FDA Authorized monoclonal antibody treatment, as an additional option for this patient population.
U.S. NIH Ranks COVID-19 Treatments
Alaskan Cruises Returning in 2022
The Port of Seattle recently unveiled its preliminary cruise schedule for 2022, with 296 scheduled sailings beginning on April 12, 2022.
This schedule should bring an estimated 1.26 million revenue passengers through Seattle’s cruise ship terminals.
With no cruise activity in 2020, the economic losses due to the drop in tourism were devastating locally and in Alaska.
And the seven significant brands homeporting in Seattle will be sailing 14 vessels, up from 11 most seasons with additional cruises to Alaska in 2022.
Newly Diagnosed Diabetes at COVID-19 Admission Profiled
Lower levels of glucose and HbA1c, higher levels of inflammatory markers seen in COVID-19 patients with NDDM versus preexisting diabetes
MIS-C Rare in 12- to 20-Year-Olds After COVID-19 Vaccination
Reporting rate was 1.0 case per million vaccinated individuals and 0.3 cases among those without evidence of SARS-CoV-2 infection
CDC Estimates U.S. COVID-19 Infections Now Close to 140 Million
New findings are from the CDC national antibody seroprevalence survey of antibodies to the coronavirus triggered by infection, not by vaccination
Biden Unveils New ‘Test to Treat’ Plan as Key Part of New COVID-19 Strategy
New testing initiative would provide Americans with new antiviral medications as soon as they learn they are infected
Biden Extends FEMA COVID-19 Aid to States
Funding supports FEMA-backed efforts such as vaccination clinics, mass testing sites